Invivyd, Inc. (IVVD): who owns it and who trades it
As of Nov 16, 2026, IVVD insiders reported 12 open-market sales worth $341K and 1 purchase worth $125K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jill Andersen (Chief Legal Officer), with $158K. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Invivyd
From the latest filingsOverall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns IVVD
126 funds and institutions reported IVVD shares worth $204M at the end of Q2 2026, about 79% of the company. The largest holder is Jupiter Topco LLC with 11.6%.
Funds and institutions (13F) 79%Everyone else 21%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Jupiter Topco LLC | 34.17M | 11.60% | $30M | – |
| Bvf Inc | 28.16M | 9.56% | $24.6M | +44% |
| Maverick Capital Ltd | 18.97M | 6.44% | $16.6M | No change |
| Perceptive Advisors LLC | 18.49M | 6.28% | $16.1M | -11% |
| BlackRock, Inc. | 16.13M | 5.48% | $14.1M | +277% |
| Vanguard Capital Management LLC | 10.50M | 3.56% | $9.2M | +4% |
| M28 Capital Management LP | 9.25M | 3.14% | $8.1M | No change |
| Saturn V Capital Management LP | 8.39M | 2.85% | $7.3M | -23% |
| Soleus Capital Management, L.P. | 7.71M | 2.62% | $6.7M | No change |
| Point72 Asset Management, L.P. | 7.54M | 2.56% | $6.6M | +17068% |
| Morgan Stanley | 5.73M | 1.95% | $5M | +69% |
| Geode Capital Management, LLC | 5.42M | 1.84% | $4.7M | +119% |
| Siren, L.L.C. | 5.00M | 1.70% | $4.4M | +25% |
| Driehaus Capital Management LLC | 4.81M | 1.63% | $4.2M | -43% |
| ADAR1 Capital Management, LLC | 3.81M | 1.29% | $3.3M | -0% |
| Adage Capital Partners Gp, L.l.c. | 3.66M | 1.24% | $3.2M | No change |
| Citadel Advisors LLC | 3.58M | 1.22% | $3.1M | +125% |
| State Street Corp | 3.46M | 1.17% | $3M | -50% |
| Qube Research & Technologies Ltd | 3.32M | 1.13% | $2.9M | +24% |
| Ikarian Capital, LLC | 2.66M | 0.90% | $2.3M | No change |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, IVVD insiders reported $125K of open-market purchases and $341K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Timothy Edward Lee | Chief Commercial Officer | Sale | 18,425 | $0.84 | $15.5K | Form 4 |
| Aug 18, 2026 | Jill Andersen | Chief Legal Officer | Sale | 30,706 | $0.84 | $25.8K | Form 4 |
| Aug 18, 2026 | Robert D. Allen III | Chief Scientific Officer | Sale | 17,043 | $0.84 | $14.3K | Form 4 |
| Aug 17, 2026 | Timothy Edward Lee | Chief Commercial Officer | Sale | 22,355 | $0.72 | $16.1K | Form 4 |
| Aug 17, 2026 | Jill Andersen | Chief Legal Officer | Sale | 37,256 | $0.72 | $26.8K | Form 4 |
| Aug 17, 2026 | Robert D. Allen III | Chief Scientific Officer | Sale | 20,679 | $0.72 | $14.9K | Form 4 |
| Feb 18, 2026 | Robert D. Allen III | Chief Scientific Officer | Sale | 19,392 | $1.58 | $30.6K | Form 4 |
| Feb 18, 2026 | Julie Green | Chief Human Resources Of | Sale | 20,964 | $1.58 | $33.1K | Form 4 |
| Feb 18, 2026 | Jill Andersen | Chief Legal Officer | Sale | 34,939 | $1.58 | $55.2K | Form 4 |
| Feb 17, 2026 | Robert D. Allen III | Chief Scientific Officer | Sale | 18,189 | $1.54 | $28K | Form 4 |
| Feb 17, 2026 | Julie Green | Chief Human Resources Of | Sale | 19,663 | $1.54 | $30.3K | Form 4 |
| Feb 17, 2026 | Jill Andersen | Chief Legal Officer | Sale | 32,771 | $1.54 | $50.5K | Form 4 |
| Nov 19, 2025 | Kevin F Mclaughlin | Director | Purchase | 50,000 | $2.50 | $125K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jill Andersen | Chief Legal Officer, Secretary | – | $158K | Aug 18, 2026 |
| Kevin F Mclaughlin | Director | $125K | – | Nov 19, 2025 |
| Robert D. Allen III | Chief Scientific Officer | – | $87.9K | Aug 18, 2026 |
| Julie Green | Chief Human Resources Officer | – | $63.4K | Feb 18, 2026 |
| Timothy Edward Lee | Chief Commercial Officer | – | $31.6K | Aug 18, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
IVVD short interest
High short interest. 12.2% of IVVD shares are sold short: about 1 share in 8. Over the last 12 reports the number of shares short went up 17%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 36.20M IVVD shares were sold short, 12.2% of the shares outstanding, down 2.3% from the report before. At the average daily volume of 3.75M shares, buying them all back would take about 9.7 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 36.20M | 12.25% | -2% | 3.75M | 9.7 |
| Oct 15, 2026 | 37.05M | 12.57% | +9% | 5.35M | 6.9 |
| Sep 30, 2026 | 33.86M | 11.49% | +11% | 9.46M | 3.6 |
| Sep 15, 2026 | 30.56M | 10.37% | +3% | 3.97M | 7.7 |
| Aug 31, 2026 | 29.79M | 10.11% | -4% | 4.49M | 6.6 |
| Aug 14, 2026 | 30.92M | 10.49% | +11% | 2.75M | 11.2 |
| Jul 31, 2026 | 27.80M | 9.43% | -5% | 3.13M | 8.9 |
| Jul 15, 2026 | 29.31M | 9.95% | +7% | 3.43M | 8.6 |
| Jun 30, 2026 | 27.44M | 9.31% | -20% | 7.62M | 3.6 |
| Jun 15, 2026 | 34.43M | 11.69% | +11% | 5.75M | 6.0 |
| May 29, 2026 | 30.93M | 10.50% | -0% | 2.91M | 10.6 |
| May 15, 2026 | 31.07M | 10.55% | +6% | 3.28M | 9.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Invivyd company events
Invivyd filed 13 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, listing). The latest was on Sep 29, 2026.
- Sep 29, 2026AnnouncementInvivyd, Inc. issued a press release entitled “Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311.” A copy of the press release is filed as… Filing
- Sep 1, 2026LeadershipThe Board of Directors of Invivyd, Inc. appointed Marc Elia, Chairman of the Board, as the Company’s Chief Executive Officer, effective as of August 30, 2026. Filing
- Aug 13, 2026ResultsReleased financial results. Filing
- Jul 24, 2026ListingInvivyd, Inc. received a deficiency letter from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC notifying the Company that, for a period of 30 consecutive business days, the bid price for the Company’s common stock, $0.0001 par value per share, had closed below the $1.00… Filing
- Jul 6, 2026AnnouncementInvivyd, Inc. issued a press release entitled “Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA.” A copy of the press release is filed as Exhibit 99.1 to this Current… Filing
- May 19, 2026VoteReported shareholder vote results. Filing
- May 14, 2026AnnouncementThe Company posted an updated corporate presentation on its website at www.invivyd.com. Filing
- Apr 9, 2026AnnouncementInvivyd, Inc. issued a press release entitled “Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles.” A copy of the press release is filed as Exhibit 99.1 to… Filing
- Mar 5, 2026AnnouncementThe Company posted an updated corporate presentation on its website at www.invivyd.com. Filing
- Jan 8, 2026AnnouncementThe Company issued the Press Release, a copy of which is filed herewith as Exhibit 99.1 and is incorporated by reference in this Item 8.01. Filing
- Dec 23, 2025AnnouncementInvivyd, Inc. issued a press release entitled “Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID.” A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference in this Item 8.01. Filing
- Nov 24, 2025AnnouncementInvivyd, Inc. issued a press release entitled “Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness.” A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference in this Item 8.01. Filing
- Nov 19, 2025AgreementInvivyd, Inc. entered into an underwriting agreement with Cantor Fitzgerald & Co., as representative of the underwriters named therein, in connection with its previously announced underwritten public offering of 44,000,000 shares of the Company’s common stock, par value $0.0001 per share, and, to… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Invivyd financials
Famous investors that hold IVVD
5 of the 50 well-known investors we track reported holding IVVD in their latest 13F filing. The largest position is Lee Ainslie's, worth $21.3M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | Q3 2026 | 24.44M | $21.3M | 0.2% | +29% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 6.88M | $6M | 0.0% | -9% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 2.36M | $2.1M | 0.0% | -34% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 943,820 | $821K | 0.0% | -5% |
| Israel Englander · Millennium Management | Q3 2026 | 45,371 | $39.5K | 0.0% | -96% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named IVVD in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Maverick Capital, Ltd. | 13G/A | 8.3% |
| Nov 16, 2026 | Perceptive Advisors LLC | 13G/A | 4.7% |
| Nov 16, 2026 | Maverick Capital, Ltd. | 13G/A | 8.3% |
| Nov 16, 2026 | Perceptive Advisors LLC | 13G/A | 4.7% |
Questions about Invivyd, Inc. (IVVD) stock
Who owns the most IVVD stock?
The largest reported owner of Invivyd, Inc. (IVVD) is Jupiter Topco LLC, with 11.6% of the company. In total, 126 funds and institutions reported holding IVVD at the end of Q2 2026, together about 79% of the shares. See the largest owners.
Are IVVD insiders buying or selling?
In the last 12 months, IVVD insiders reported 1 open-market purchase worth $125K and 12 sales worth $341K. The latest trade was on Aug 18, 2026. See every trade.
What is the short interest in IVVD?
As of Oct 30, 2026, 36.20M IVVD shares were sold short, 12.2% of the shares outstanding, down 2.3% from the report before. At the average daily volume of 3.75M shares, buying them all back would take about 9.7 trading days (days to cover). See the history.
Which famous investors hold IVVD?
5 of the 50 well-known investors we track reported IVVD in their latest 13F filing, including Lee Ainslie, Steve Cohen, Ken Griffin. The largest position is worth $21.3M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.